Healthcare provider profile · identity verified

Amit Bhandari, MD

Allopathic & Osteopathic Physicians|Internal Medicine · SALEM, OR · NPI 1669456448

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Amit Bhandari, MD received $154.99 in general payments during 2025 across 2 reported records.

Medtronic, Inc. accounted for 78.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$154.99

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Medtronic, Inc.	Medtronic, Inc. exact · evidence 2025-07-22	$121.27	78.2%	1	2025
Terumo Medical Corporation	Unresolved — no canonical attribution shown	$33.72	21.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$154.99	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
SYMPLICITY G3 Normalized: symplicity g3	Device	Medtronic, Inc.	$121.27	1	2025
Source payment records 2025-12-04 · Medtronic, Inc. · $121.27 · Open Payments source
ANGIO-SEAL Normalized: angio seal	Device	Terumo Medical Corporation	$33.72	1	2025
Source payment records 2025-09-03 · Terumo Medical Corporation · $33.72 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	422	168
Losartan Potassium	Losartan Potassium	353	129
Levothyroxine Sodium	Levothyroxine Sodium	302	109
Amlodipine Besylate	Amlodipine Besylate	247	110
Lisinopril	Lisinopril	234	84
Trazodone Hcl	Trazodone Hcl	176	57
Gabapentin	Gabapentin	168	55
Furosemide	Furosemide	163	55
Omeprazole	Omeprazole	163	58
Rosuvastatin Calcium	Rosuvastatin Calcium	154	65
Metoprolol Succinate	Metoprolol Succinate	138	60
Tamsulosin Hcl	Tamsulosin Hcl	137	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	135	54
Metformin Hcl	Metformin Hcl	128	47
Pantoprazole Sodium	Pantoprazole Sodium	105	43
Albuterol Sulfate Hfa	Albuterol Sulfate	103	53
Metoprolol Tartrate	Metoprolol Tartrate	87	35
Pravastatin Sodium	Pravastatin Sodium	86	42
Allopurinol	Allopurinol	82	28
Ozempic	Semaglutide	82	12
Duloxetine Hcl	Duloxetine Hcl	81	30
Donepezil Hcl	Donepezil Hcl	80	24
Potassium Chloride	Potassium Chloride	78	31
Alendronate Sodium	Alendronate Sodium	75	29
Hydrochlorothiazide	Hydrochlorothiazide	74	33
Oxycodone Hcl	Oxycodone Hcl	74	32
Eliquis	Apixaban	66	25
Sertraline Hcl	Sertraline Hcl	64	27
Fluoxetine Hcl	Fluoxetine Hcl	61	17
Glipizide	Glipizide	57	18
Famotidine	Famotidine	56	16
Quetiapine Fumarate	Quetiapine Fumarate	56	suppressed
Simvastatin	Simvastatin	55	25
Meloxicam	Meloxicam	53	27
Buspirone Hcl	Buspirone Hcl	52	14
Clonazepam	Clonazepam	52	suppressed
Januvia	Sitagliptin Phosphate	51	13
Montelukast Sodium	Montelukast Sodium	44	15
Clopidogrel	Clopidogrel Bisulfate	41	14
Metformin Hcl Er	Metformin Hcl	41	20
Azithromycin	Azithromycin	40	29
Baclofen	Baclofen	40	21
Mirtazapine	Mirtazapine	39	16
Triamcinolone Acetonide	Triamcinolone Acetonide	39	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	16
Zolpidem Tartrate	Zolpidem Tartrate	39	16
Prednisone	Prednisone	38	32
Atenolol	Atenolol	37	16
Bupropion Xl	Bupropion Hcl	37	16
Citalopram Hbr	Citalopram Hydrobromide	37	15
Finasteride	Finasteride	36	12
Pregabalin	Pregabalin	36	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	21
Escitalopram Oxalate	Escitalopram Oxalate	35	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	12
Spironolactone	Spironolactone	35	suppressed
Ondansetron Odt	Ondansetron	34	11
Promethazine Hcl	Promethazine Hcl	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	17
Clonidine Hcl	Clonidine Hcl	32	suppressed
Estradiol	Estradiol	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Lorazepam	Lorazepam	30	19
Paroxetine Hcl	Paroxetine Hcl	30	12
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	12
Nystatin	Nystatin	29	13
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Carvedilol	Carvedilol	28	14
Doxycycline Hyclate	Doxycycline Hyclate	28	19
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Alprazolam	Alprazolam	24	11
Jardiance	Empagliflozin	24	12
Glipizide Er	Glipizide	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Cephalexin	Cephalexin	20	20
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Phenobarbital	Phenobarbital	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	16
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	11
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Diazepam	Diazepam	11	suppressed
Digoxin	Digoxin	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Myrbetriq	Mirabegron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$154.99 · 2 records	Medtronic, Inc.	ANGIO-SEAL, SYMPLICITY G3	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error